127 related articles for article (PubMed ID: 6389484)
1. Serum profile and bioavailability of a controlled-release theophylline formulation for once-daily use: comparison with a 12-hr preparation.
Cohen BM
J Asthma; 1984; 21(5):305-9. PubMed ID: 6389484
[TBL] [Abstract][Full Text] [Related]
2. Treatment of asthma by a controlled-release theophylline tablet formulation: a review of the North American experience with nocturnal dosing.
Goldenheim PD; Conrad EA; Schein LK
Chronobiol Int; 1987; 4(3):397-408. PubMed ID: 3315269
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
Rivington RN; Calcutt L; Hodder RV; Stewart JH; Aitken TL
Am J Med; 1988 Jul; 85(1B):48-53. PubMed ID: 3041826
[TBL] [Abstract][Full Text] [Related]
4. Theophylline absorption from sustained-release products: comparative steady-state bioavailability of once-daily Theo-Dur, Theo-24, and Uniphyl.
Hurwitz A; Karim A; Burns TS
J Clin Pharmacol; 1987 Nov; 27(11):855-61. PubMed ID: 3429692
[TBL] [Abstract][Full Text] [Related]
5. Is a uniform round-the-clock theophylline blood level necessary for optimal asthma therapy in the adolescent patient?
Bierman CW; Pierson WE; Shapiro GG; Furukawa CT
Am J Med; 1988 Jul; 85(1B):17-20. PubMed ID: 3041822
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a new sustained-release theophylline preparation, TheoBeads, with Theo-Dur tablets in children with asthma.
Welch MJ; Orgel HA; Meltzer EO; Kemp JP; Gawchik S; Rooklin AR; Tinkelman DG
J Asthma; 1988; 25(5):269-74. PubMed ID: 3182591
[TBL] [Abstract][Full Text] [Related]
7. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.
Weinberger MM
Pharmacotherapy; 1984; 4(4):181-98. PubMed ID: 6483637
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
9. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics.
Arkinstall WW; Atkins ME; Harrison D; Stewart JH
Am Rev Respir Dis; 1987 Feb; 135(2):316-21. PubMed ID: 3813191
[TBL] [Abstract][Full Text] [Related]
10. Multicenter comparison of once-daily Uniphyl tablets administered in the morning or evening with baseline twice-daily theophylline therapy in patients with nocturnal asthma.
Grossman J
Am J Med; 1988 Jul; 85(1B):11-3. PubMed ID: 3041821
[TBL] [Abstract][Full Text] [Related]
11. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new sustained-release theophylline tablet for children.
Selvig K; Alme A; Rugstad HE; Aas K; Bjerve KS
Acta Paediatr Scand; 1981 Nov; 70(6):929-33. PubMed ID: 7324949
[TBL] [Abstract][Full Text] [Related]
13. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability and pharmacological effects of two slow-release theophylline preparations: intrasubject tablet-to-tablet variability.
Rivera-Calimlim L; Calimlim JF; Liang R; Lasagna L; Diamond GL
J Asthma; 1986; 23(3):113-22. PubMed ID: 3528119
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of a once daily-administered theophylline preparation. A comparison study.
Mangura BT; Maniatis T; Abdel Rahman MS; Bartholf R; Lavietes MH
Chest; 1986 Oct; 90(4):566-70. PubMed ID: 3757567
[TBL] [Abstract][Full Text] [Related]
16. Sustained-release theophylline preparations in asthmatic children. A short-term comparison of two products and the relationship of serum theophylline levels and pulmonary function changes.
Rachelefsky G; Rohr A; Katz R; Wo J; Gracey V; Spector S; Siegel S; Mickey MR
Am J Dis Child; 1986 Apr; 140(4):336-40. PubMed ID: 3513540
[TBL] [Abstract][Full Text] [Related]
17. Conversion from twice- to once-daily extended-release theophylline treatment in patients with reversible airway obstruction.
Berkowitz RB; Tinkelman DG; Marcoux JP; Rooklin AR; Zeitz HJ; Rennard SI; Moss BA; Hubbard RC; Lorber RR
J Asthma; 1995; 32(4):275-84. PubMed ID: 7629003
[TBL] [Abstract][Full Text] [Related]
18. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
[TBL] [Abstract][Full Text] [Related]
19. Steady-state evaluation of twice-a-day dosing of a new sustained-release theophylline preparation for young children.
Welch MJ; Kemp JP; Orgel HA; Meltzer EO
J Asthma; 1985; 22(5):249-52. PubMed ID: 4055657
[TBL] [Abstract][Full Text] [Related]
20. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
